Your browser doesn't support javascript.
loading
Protein phosphorylation and kinases: Potential therapeutic targets in necroptosis.
Shi, Yihui; Wu, Chengkun; Shi, Jiayi; Gao, Taotao; Ma, Huabin; Li, Long; Zhao, Yufen.
Afiliação
  • Shi Y; Institute of Drug Discovery Technology, Ningbo University, Ningbo, Zhejiang, 315211, China.
  • Wu C; School of Medicine, Nankai University, Tianjin, 300071, China.
  • Shi J; Institute of Drug Discovery Technology, Ningbo University, Ningbo, Zhejiang, 315211, China.
  • Gao T; Institute of Drug Discovery Technology, Ningbo University, Ningbo, Zhejiang, 315211, China.
  • Ma H; Central Laboratory, The First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, China. Electronic address: mahuabin@fjmu.edu.cn.
  • Li L; Institute of Drug Discovery Technology, Ningbo University, Ningbo, Zhejiang, 315211, China. Electronic address: lilong@nbu.edu.cn.
  • Zhao Y; Institute of Drug Discovery Technology, Ningbo University, Ningbo, Zhejiang, 315211, China.
Eur J Pharmacol ; 970: 176508, 2024 May 05.
Article em En | MEDLINE | ID: mdl-38493913
ABSTRACT
Necroptosis is a pivotal contributor to the pathogenesis of various human diseases, including those affecting the nervous system, cardiovascular system, pulmonary system, and kidneys. Extensive investigations have elucidated the mechanisms and physiological ramifications of necroptosis. Among these, protein phosphorylation emerges as a paramount regulatory process, facilitating the activation or inhibition of specific proteins through the addition of phosphate groups to their corresponding amino acid residues. Currently, the targeting of kinases has gained recognition as a firmly established and efficacious therapeutic approach for diverse diseases, notably cancer. In this comprehensive review, we elucidate the intricate role of phosphorylation in governing key molecular players in the necroptotic pathway. Moreover, we provide an in-depth analysis of recent advancements in the development of kinase inhibitors aimed at modulating necroptosis. Lastly, we deliberate on the prospects and challenges associated with the utilization of kinase inhibitors to modulate necroptotic processes.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Quinases / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Quinases / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article